Richiedi una copia del documento: Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer : a retrospective, exploratory analysis of the CORRECT trial

Captcha code
Annulla